Dr Mary Jo DiMilia (MD) is on staff at the Mount Sinai Medical Center in New York, is the founder and former director of the Combined Internal Medicine and Paediatrics Residency Program and currently holds faculty positions as Clinical Assistant Professor of Medicine and Clinical Assistant Professor of Paediatrics at the Icahn School of Medicine at Mount Sinai.
Dr DiMilia is bringing new evidence-based, adjunctive treatment for cancer patients through the use of repurposed or off-label prescription medications combined with vitamins and supplements. Each patient’s protocol is comprehensive and personalised with scientific evidence to support its use. The repurposed prescription medications will make cancer more sensitive to radiation and chemotherapy, in addition to enhancing the metabolic approach to deprive cancer cells and increasing cancer cell apoptosis (death of cells).
Innovative healthcare incorporating vitamins, supplements and repurposed medications or “off-label drugs as adjunct treatment for cancer patients of all ages